Abstract Submission Tutorial - ARVO

Abstract Submission - Step 2: Disclosure• Acknowledge your affirmations by selecting each box.- First Author is obligated to register and pay the fees to attend the 2012 AnnualMeeting if the abstract is accepted for presentation.- First Author must be the presenting author at the Annual Meeting and present thesame work submitted in the abstract.- First Author must reveal the essential structure (DNA sequence), the elements of anovel compound, or sufficient identification of new gene compounds (drugs, genes,etc.) in the presentation, if applicable.- The abstract represents data and conclusions not previously published norpreviously presented at ARVO by the same investigator, nor were redundant withabstracts submitted in the same year by the same group of investigators.- Any research reported was conducted in compliance with the ARVO Statement forthe Use of Animals in Ophthalmic and Visual Research and/or the Declarationof Helsinki.- First Author understands ARVO’s requirement to register a clinical trial prior toreporting on the trial in compliance with ARVO’s Clinical Trials Policy.- All co-authors of the abstract must provide a written transfer of copyright for thecontributions he/she made to the abstract. This should be submitted to the FirstAuthor who must convey copyright ownership of the abstract to ARVO on behalf ofall the authors. Click here for Copyright Transfer Document.www.arvo.org | www.iovs.org | journalofvision.org | tvstjournal.org